Literature DB >> 8420812

Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study.

P A Morales1, B D Mitchell, R A Valdez, H P Hazuda, M P Stern, S M Haffner.   

Abstract

Hypertension often occurs in association with NIDDM and IGT. We examined the association of hypertension at baseline to the 8-yr incidence of NIDDM and IGT in 1471 subjects who participated in the San Antonio Heart Study. Subjects who were hypertensive at baseline had a higher incidence of NIDDM (8.9 vs. 4.9%, P = 0.041) and IGT (25.2 vs. 10.0%, P < 0.001) than subjects who were normotensive at baseline. After adjusting for age, sex, ethnicity, obesity, body fat distribution, fasting glucose, and insulin, this excess was eliminated for NIDDM, but not for IGT. Specifically, the adjusted OR for NIDDM in hypertensive versus normotensive patients was 0.73 (95% Cl 0.34-1.58), whereas the adjusted OR for IGT was 1.87 (95% Cl 1.08-3.22). The excess risk of NIDDM in hypertensive patients can be explained by their greater age, obesity, more unfavorable body fat distribution, and hyperinsulinemia, whereas the excess risk of IGT is independent of these factors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8420812     DOI: 10.2337/diab.42.1.154

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

Review 1.  Risk of diabetic nephropathy in potential living related kidney donors.

Authors:  D Simmons; M Searle
Journal:  BMJ       Date:  1998-03-14

2.  Does impaired glucose tolerance predict hypertension? A prospective analysis.

Authors:  O Vaccaro; G Imperatore; V Iovino; C Iovine; A A Rivellese; G Riccardi
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

Review 3.  Risk factors preceding type 2 diabetes and cardiomyopathy.

Authors:  Shamjeet Singh; Sanjiv Dhingra; Dan D Ramdath; Sudesh Vasdev; Vicki Gill; Pawan K Singal
Journal:  J Cardiovasc Transl Res       Date:  2010-07-01       Impact factor: 4.132

Review 4.  Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes.

Authors:  K G Dawson; J K McKenzie; S A Ross; J L Chiasson; P Hamet
Journal:  CMAJ       Date:  1993-09-15       Impact factor: 8.262

5.  Daily life activity and risk of developing impaired fasting glucose or type 2 diabetes in middle-aged Japanese men.

Authors:  N Nakanishi; T Takatorige; K Suzuki
Journal:  Diabetologia       Date:  2004-10-21       Impact factor: 10.122

Review 6.  Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.

Authors:  André J Scheen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study.

Authors:  O Samuelsson; K Pennert; O Andersson; G Berglund; T Hedner; B Persson; H Wedel; L Wilhelmsen
Journal:  BMJ       Date:  1996-09-14

8.  Hypertension and overweight associated with hyperinsulinaemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study.

Authors:  E J Feskens; J Tuomilehto; J H Stengård; J Pekkanen; A Nissinen; D Kromhout
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

9.  Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  L Groop; A Ekstrand; C Forsblom; E Widén; P H Groop; A M Teppo; J Eriksson
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

10.  Correlation between changes of blood pressure with insulin resistance in type 2 diabetes mellitus with 4 weeks of pioglitazone therapy.

Authors:  L M Hettihewa; S S Jayasinghe; K G Imendra; T P Weerarathna
Journal:  Int J Diabetes Dev Ctries       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.